Staphylococcal Toxins Augment Specific IgE Responses by Atopic Patients Exposed to Allergen  by Hofer, Michaël F. et al.
Staphylococcal Toxins Augment Specific IgE Responses by
Atopic Patients Exposed to Allergen
Michae¨l F. Hofer,* Ronald J. Harbeck,* Patrick M. Schlievert,† and Donald Y.M. Leung*‡
*Departments of Pediatrics and Medicine, The National Jewish Medical and Research Center, Denver, Colorado, U.S.A.; †Department of
Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota, U.S.A.; ‡Department of Pediatrics, University of Colorado Health
Sciences Center, Denver, Colorado, U.S.A.
Microbial agents are known to play a significant role
in aggravating allergic diseases. Recently described
viral and bacterial superantigens represent one import-
ant strategy by which infectious agents can stimulate
the immune response. In previous work, we reported
that the staphylococcal toxin toxic shock toxin-1
(TSST-1), a prototypic superantigen, induces in vitro
total IgE synthesis after cross-linking T and B cells.
This study was carried out to establish a potential link
between superantigens and the enhanced IgE response
to specific allergens in allergic patients. Peripheral
blood mononuclear cells from atopic patients were
isolated during and outside the pollen allergen season
and stimulated with TSST-1, a prototypic superanti-
gen. Total IgE and interferon-g production were meas-
ured in supernatants of these cultures. Outside the
pollen season, TSST-1 significantly increased total
IgE production only in the presence of exogenous
interleukin-4, whereas during the pollen season IgE
production was significantly enhanced without the
Allergic diseases, such as asthma and atopic dermatitis(AD), are characterized by increased production ofIgE directed against specific allergens, triggeringinflammation in the target organ (Leung, 1993a,1994). Aside from allergens, it has been shown that
microbial antigens, like staphylococcal toxins in AD patients or
viral antigens in asthma patients, may influence the course of
allergic diseases (McIntosh et al, 1973; Leyden et al, 1974). Based
on these clinical observations, the potential role of infectious
antigens in triggering the IgE response in allergic patients was
proposed over 20 y ago (McIntosh et al, 1973); however, the
mechanism by which this occurs is unknown.
AD is a chronic inflammatory skin disorder that frequently occurs
in patients with respiratory allergy (Leung et al, 1993b). More than
80% of patients with AD have elevated serum IgE, and clinical
evidence of allergies, i.e., foods and inhalants, can exacerbate their
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need of exogenous interleukin-4. This increase in the
absence of exogenous interleukin-4 was associated
with significantly lower interferon-g production by
peripheral blood mononuclear cells stimulated by
TSST-1 during the pollen season. Moreover, TSST-1
stimulation of peripheral blood mononuclear cells
from inhalant allergic patients was followed by an
increased production of allergen-specific IgE that was
restricted to the allergen to which the patient was
allergic and recently exposed. In addition, TSST-1
induced on B cells the expression of B7.2, a molecule
that has recently been demonstrated to enhance T
helper 2 responses and to be involved in IgE regulation.
This study, by demonstrating that superantigens can
augment allergen-specific IgE synthesis and B7.2
expression, provides a mechanism by which microbial
superantigens may modulate allergic responses. Key
words: allergy/dermatitis/superantigens/T cells. J Invest
Dermatol 112:171–176, 1999
skin disease (Burks et al, 1988; Norris et al, 1988; Leung, 1995). In
acute AD skin lesions, T cells secrete a T helper (Th) 2 cytokine
profile [interleukin (IL)-4, IL-5, IL-13], which is known to induce
IgE production (Van der Heijden et al, 1991; Hamid et al, 1994).
Furthermore, Langerhans cells infiltrating into the AD skin lesions
bear IgE on their cell surface (Bruijnzeel-Koomen et al, 1986;
Leung et al, 1987; de Bieber et al, 1992). These cells may play an
important role in cutaneous allergen presentation to Th 2 cells and
contribute to atopic skin inflammation (Mudde et al, 1990). AD is
an interesting disease model to investigate the events involved in
IgE sensitization, because AD is an early manifestation of atopy in
children, and nearly 80% of these children develop allergic rhinitis
and asthma later in childhood (Leung, 1995). Of note, most AD
patients are colonized by S. aureus (Hauser et al, 1985; Lever et al,
1988; Hoeger et al, 1992) on their skin and a majority of these
strains secrete exotoxins that can trigger skin inflammatory responses
(Marrack and Kappler, 1990).
Staphylococcal toxins, such as toxic shock syndrome toxin-1
(TSST-1), are prototypic superantigens leading to a polyclonal
expansion of T lymphocytes expressing a specific T cell receptor
variable region BV gene and the production of high cytokine levels
(Marrack and Kappler, 1990). Superantigens are also able to activate
B lymphocytes by bridging the T cell receptor on the T lymphocyte
with the class II major histocompatibility molecule on the B
lymphocyte (Mourad et al, 1989). We have previously shown that
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Figure 1. Stimulation of IgE
production by TSST-1 during and
outside the pollen season. PBMC from
eight pollen-allergic subjects isolated
outside (A) or during (B) the pollen season
were incubated with TSST-1 at a
concentration of 0.01 pg per ml in the
presence or absence of exogenous
recombinant IL-4. IgE production was
measured by enzyme-linked immuno-
sorbent assay after 14 d of culture. Mean
6 SEM of eight experiments [medium
alone (0, u) versus TSST-1 (r): *p,0.05]
are shown.
in vitro TSST-1 at low concentrations is able to stimulate IgE
production by peripheral blood mononuclear cells (PBMC) from
AD patients, and that this IgE production was inhibited by interferon
(IFN)-γ at higher TSST-1 concentrations (Hofer et al, 1995).
Increased IgE production was secondary to T cell-dependent
polyclonal B cell activation after bridging of T and B cells by
TSST-1. In this regard, TSST does not induce purified B cells to
synthesize IgE in the absence of T cells. Furthermore, anti-LFA-1
monoclonal antibodies inhibit TSST-1 enhanced IgE synthesis. In
contrast to anti-CD40 antibodies, TSST-1 did not induce IgE
synthesis by purified B cells, which implies that TSST-1-induced
IgE synthesis is T cell dependent. In this study, we show that
staphylococcal toxins augment IgE response to specific allergens.
These data provide for the first time a mechanism by which
infectious agents may affect the course of allergic responses, in
particular that staphylococcal infection in AD may augment IgE
sensitization to inhalant allergens, and thereby contribute to the
development of respiratory allergy.
MATERIALS AND METHODS
Subjects For the studies during and outside the pollen season we
investigated eight patients with moderate to severe AD (greater than 20%
of skin involvement). Their diagnosis was based on well-defined criteria
(Hanifin and Rajka, 1980; Leung et al, 1993b). All patients had a history
of AD dating back to early infancy and had flexural eczema. These patients
had concomitant asthma or allergic rhinitis and were allergic to grass and/
or ragweed pollen, as demonstrated by positive immediate skin test reactivity
to grass and ragweed, respectively, and a prior history of increased asthmatic
or rhinitis symptoms during the allergen season (late spring and/or
fall). None of the patients had previously used systemic corticosteroids.
Heparinized blood was collected from all pollen sensitive patients at two
separate time points: during the pollen season (grass or ragweed, depending
on the pollen to which the patient was sensitized) and outside the pollen
season (December and January).
For allergen-specific IgE studies, blood was obtained from four cat-
allergic patients (two of them were living with their cats and two were
not exposed to cat allergen during the study period) and from four pollen-
allergic patients (two of them during the pollen season and two during the
winter). These patients had respiratory symptoms (asthma and/or rhinitis
when exposed to the allergen to which they are sensitized), but none had
AD. Control blood was obtained from eight healthy nonatopic subjects,
who had no personal history of atopic diseases, asthma or skin disease and
were skin test negative to allergens. Informed consent was obtained from
every participant to the study before blood was drawn.
Cell cultures PBMC were isolated from heparinized venous blood
by density gradient centrifugation on Ficoll-Paque (Pharmacia, Uppsala,
Sweden) and resuspended at 2 3 106 in enhanced Iscove’s modified
Dulbecco’s medium with 10% heat inactivated fetal calf serum, as described
previously (Yssel et al, 1984). PBMC were incubated in the absence
or presence of 400 U recombinant IL-4 (Schering Research Institute,
Bloomfield, NJ) per ml with a range of TSST-1 concentrations (1000–
0.001 pg per ml). Purified TSST-1 was prepared by P.M.S. as previously
described (Blomster-Hautamaa and Schlievert, 1988). After 2 d of culture
for cytokine production or 14 d for IgE production, supernatants were
collected and stored at –20°C until assayed.
Enzyme-linked immunosorbent assay for immunoglobulin and
cytokine determination Total IgE and IgG were measured by a specific
enzyme-linked immunosorbent assay, as described previously in Jujo et al
(1993), read at 405 nm on an Emax microplate reader (Molecular Devices,
Menlo Park, CA). The IgE assay did not detect polyclonal IgG and
therefore did not detect idiotypic determinants. The concentrations of IgE
and IgG in the supernatants were read from a standard curve. The lower
limit of sensitivity of this assay was 500 pg per ml. Preformed IgE was
measured by acid elution, as described previously (Turner et al, 1983) and
was less than 500 pg per ml in all experiments. IFN-γ was measured by a
commercially available enzyme immunoassay kit (Endogen, Boston, MA)
with a lower limit of sensitivity of 5 pg per ml (0.1 U per ml). Specific
IgE to timothy, ragweed, and cat allergen were measured by the CAP
system. Results were given in kU per liter (Zieg et al, 1994). Before
running the assay, the supernatants were concentrated 10 times using
Centricon centrifugal concentrators (Amicon, Beverly, MA) with a 10,000
MW cut-off. The lower limit of sensitivity of the CAP system was 35 U
per liter (0.035 kU per liter).
Cell staining and flow cytometric analysis Four-parameter analysis
was performed using a FACScalibur flow cytometer (Becton Dickinson,
Mountain View, CA) with fluorescein isothiocyanate and phycoerythrin
used as the two fluorescent parameters. PBMC were washed twice in
phosphate buffer saline containing 1% human immunoglobulins (Armour
Pharmaceutical, Kankakee, IL) and 0.02% NaN3, and stained for 30 min
at 4°C with anti-CD19 fluorescein isothiocyanate- (Becton Dickinson)
and anti-B7.1 (CD80) phycoerythrin- or anti-B7.2 (CD86) phycoerythrin-
conjugated monoclonal antibodies (Ancell, Bayport, MN). Cells were
washed three times in phosphate buffer saline before analysis. Methods of
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Figure 2. Stimulation of IgE production by TSST-1 in three
consecutive seasons. PBMC from three pollen-allergic subjects, isolated
outside, during, and outside the pollen season, were stimulated with
TSST-1 in the absence of exogenous IL-4 as for Fig 1.
cytometer set up and data acquisition were as described previously
(Funderud et al, 1987). List mode multiparameter data files (each file with
forward scatter, side scatter, and two fluorescent parameters) were analyzed
by use of the CellQuest MacIntosh program (Becton Dickinson). Negative
control reagents were used to verify the staining specificity of experimental
antibodies.
Statistical analysis Data are expressed as the mean 6 SEM. Due to the
exponential range of the data, log transformation was performed before
the data were analyzed by unpaired or paired Student’s t test.
RESULTS
TSST-1-enhanced IgE response is primed during the pollen
season Initially, we examined the role of in vivo allergen exposure
for priming the IgE response to TSST-1 stimulation. PBMC were
isolated from eight AD patients with pollen allergy, during and
outside the pollen season, and stimulated with a range of TSST-1
concentrations in the presence or in the absence of exogenous IL-
4. We chose the TSST-1 concentrations for our experiments based
on previous studies, where we showed that higher concentrations
inhibited IgE production by inducing B cell apoptosis (Hofer et al,
1996). As shown on Fig 1, the spontaneous IgE production in the
absence of exogenous IL-4 was only increased significantly during
the pollen season (medium alone, 32.0 6 6.2 ng per ml; TSST-1,
61.5 6 14.6 ng per ml, p , 0.05); however, TSST-1 enhanced
IL-4-induced IgE production both outside (medium alone,
9.8 6 1.5 ng per ml; TSST-1, 24.1 6 2.2 ng per ml, p , 0.05)
and during the pollen season (medium alone, 155.7 6 37.1 ng per
ml; TSST-1, 401.8 6 108.9 ng per ml, p , 0.05). Under all
conditions, IgE production was significantly higher (p , 0.05)
during the pollen season compared with outside the pollen season.
In three patients studied for three consecutive seasons (outside,
during, and outside the pollen season), TSST-1-induced IgE
production reproducibly dropped outside the pollen season (Fig 2).
As a control, we measured the spontaneous and the TSST-1-
induced IgG production, which were not affected by the season
Figure 3. Stimulation of IgG production by TSST-1 during and
outside the pollen season. PBMC from eight pollen-allergic subjects,
isolated outside (u) or during (r) the pollen season, were incubated with
TSST-1 at concentrations of 0.1 and 0.01 pg per ml in the absence of
exogenous IL-4. Mean 6 SEM of all experiments (during versus outside
pollen season: all p.0.50).
(Fig 3). Furthermore, the frequency of B cells was similar in resting
and TSST-1-stimulated PBMC samples drawn before and during
the pollen season: in medium controls, the mean percentage of B
cells was 6.1% during pollen season and 5.6% outside pollen season.
Following TSST-1 stimulation, the mean percentage of B cells was
7.9% during pollen season and 7.5% outside pollen season. These
data highlight the role of allergen exposure in priming for the
enhanced IgE production by TSST-1.
TSST-1-induced IFN-g synthesis is decreased during allergen
exposure Allergic patients have in common the predominance
of a Th2-type cytokine profile, in particular IL-4 and IL-13,
favoring IgE production, in contrast to nonatopic persons, where
Th1-type cytokines predominate, such as IFN-γ, which is known
to inhibit IgE synthesis (Rousset et al, 1991; Hamid et al, 1994;
Lester et al, 1995). We hypothesized that low IFN-γ production
contributed to the seasonal difference in TSST-1-stimulated IgE
production. PBMC from eight pollen-allergic AD patients and
eight nonatopic controls were cultured in medium alone or
stimulated for 48 h with a range of TSST-1 concentrations followed
by the measurement of IFN-γ and IL-4 in the culture supernatants.
As shown in Fig 4, IFN-γ production induced by 10 pg TSST-1
per ml in PBMC from AD patients with pollen allergy was
significantly lower during (142 6 22 pg per ml) than outside the
pollen season (2151 6 499 pg per ml, p 5 0.02). Results were
similar for TSST-1 concentrations higher than 10 pg per ml;
however, the spontaneous IFN-γ production was similar regardless
of the season. The PBMC from nonatopic controls did not show
any significant difference for the TSST-1-induced IFN-γ production
during versus outside the pollen season. TSST-1 concentrations
lower than 10 pg per ml did not induce sufficient enough IFN-γ to
detect significant differences in seasonal production or a significant
difference between subject groups studied. IL-4 production was
too low to detect in both resting and TSST-1-stimulated cultures.
This decreased IFN-γ production during season, as well as the need
for exogenous IL-4 for the TSST-1-enhanced IgE production
outside the pollen season, resulted in the higher TSST-1-induced
IgE production after allergen exposure. When PBMC from allergic
patients drawn outside the pollen season were stimulated with a
mitogen, phytohemagglutin, at the concentration of 2 µg per ml,
the IFN-γ production was much lower (96.1 6 63.3 pg per ml)
than after stimulation with TSST-1 (2151 6 499 pg per ml). For
PBMC from nonatopics, the difference was much less (phytohemag-
glutin, 1149.6 6 1042.1; TSST-1, 5505.1 6 1688.0 pg per ml).
Furthermore, in cultures done outside the pollen season when
IFN-γ was blocked by neutralizing antibodies, TSST-1-stimulated
IgE production was significantly enhanced (data not shown).
Similarly, we showed previously that neutralizing anti-IFN-γ anti-
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Figure 4. Stimulation of IFN-g
production by TSST-1 during and
outside the pollen season. PBMC from
eight pollen-allergic subjects (A) and eight
non-atopic controls (B), isolated outside
(u) or during (r) the pollen season, were
incubated with TSST-1 at a concentration
of 10 pg per ml. IFN-γ production was
measured by enzyme-linked immuno-
sorbent assay after 2 d of culture. Mean
6 SEM of all experiments (during versus
outside pollen season: *p50.02).
Table I. TSST-1 stimulates specific IgE production in cat
and pollen allergic patientsa
Allergen specific IgE production (U/l)
Patient 1 Patient 2 Patient 3 Patient 4 P valueb
Medium ,0.35 ,0.35 ,0.35 ,0.35 –
TSST-1 68.8 202.5 208.0 47.4 0.04
(0.01 pg per ml)
TSST-1 106.3 387.2 242.0 43.6 0.01
(0.1 pg per ml)
IL-4 54.3 166.3 117.0 38.7 –
aPBMC from patients without AD, but allergic to cats and living with a cat
(patients 1 and 2), or pollen allergic patients in pollen season (patients 3 and 4), were
stimulated with or without TSST-1 for 14 d in the presence or in the absence of
IL-4 (400 U per ml). At the end of the culture, supernatants were harvested and
analyzed for the cat-allergen (patients 1 and 2) or pollen-allergen (patients 3 and 4)
specific IgE content by the CAP system.
bP-values comparing IL-4 versus IL-4 1 TSST-1.
bodies significantly increased TSST-1-induced IgE production in
nonatopic individuals (Lester et al, 1995).
TSST-1 increases the production of allergen-specific IgE in
allergic patients Previous studies have demonstrated a significant
association between allergen-specific IgE and allergic diseases
(Sampson, 1989; Gerriten et al, 1990; Nelson et al, 1996). In order
to explore a potential link between staphylococcal toxin exposure
and allergen-specific IgE responses, we examined the effect of
TSST-1 on allergen-specific IgE production. PBMC from pollen-
and cat-allergic patients were stimulated with TSST-1 in the
presence of IL-4 (400 U per ml) and analyzed after 14 d of culture
for allergen-specific IgE. As shown in Table I, TSST-1 enhanced
cat-allergen specific IgE production in PBMC from cat allergic
patients living with their cats and symptomatic at the time of blood
draw. In contrast, in asymptomatic patients without recent exposure
to cat allergen, cat-allergen-specific IgE was below 0.35 U per liter
(detection limit of the assay) in all culture condition tested. The
increase in allergen-specific IgE was only observed for the allergen
to which the patient was sensitized. Similar results for specific IgE
production to grass and ragweed pollen were found with PBMC
from four pollen allergic patients (the two patients, who were
symptomatic and whose blood was drawn during pollen season,
are shown in Table I). Allergen-specific IgE could not be measured
after stimulation with TSST-1 of PBMC from nonatopic controls.
With these experiments, we show that TSST-1 is able to stimulate
the production of allergen-specific IgE in PBMC from allergic
patients.
TSST-1 upregulates B7.2, but not B7.1, at the B cell
surface A costimulatory signal, provided by the interaction
between the B7 family of molecules (B7.1 or B7.2) expressed on
antigen-presenting cells and CD28, a T cell surface molecule, is
necessary in order to activate T cells. Based on work done in mice,
B7.2 appears to enhance Th2 cell activation (Gerriten et al, 1990).
Furthermore, we recently showed that B7.2 is upregulated on the
B cell surface from patients exposed to allergens (Hofer et al, 1998),
and that B7.21 B cells produce significantly higher amounts of IgE
than B7.2– B cells (Jirapongsananuruk et al, 1998). Therefore, we
hypothesized that the B7/CD28 pathway may be differentially
affected by the enhancing effect of TSST-1 on allergen-specific
IgE production. We examined, by flow cytometry, the expression
of both B7 molecules on B cells from four normal and five atopic
donors after 2 d stimulation with a range of TSST-1 concentrations.
TSST-1 had similar effects on normal and atopic B cells. As shown
in Table II, TSST-1 significantly upregulated B7.2, but not B7.1,
on B cells from nonatopic controls (medium alone, 33.3 6 8.7%;
TSST-1 at 1 pg per ml, 47.9 6 3.6%, p 5 0.05; TSST-1 at 100 ng
per ml, 53.5 6 10.0%, p 5 0.05), and in atopics (medium alone,
59.3 6 5.5%; TSST-1 at 1 pg per ml, 67.3 6 5.6%, p 5 0.05;
TSST-1 at 100 ng per ml, 79.4 6 2.3%, p 5 0.006).
DISCUSSION
This study demonstrates a potential mechanism by which microbial
agents could increase IgE production in allergic patients and enhance
their sensitization to allergens. First, we showed the importance of
in vivo allergen exposure for priming total IgE responses to
TSST-1 stimulation. In vivo allergen priming during the pollen
season significantly decreased TSST-1-mediated IFN-γ production
and was associated with increased TSST-1-induced IgE production.
Of note, in PBMC primed by in vivo allergen exposure, TSST-1
increased IgE production even in the absence of exogenous IL-4.
Anti-IL-4 neutralizing antibodies did not significantly block
TSST-1-induced IgE production. These data suggest that the effect
of TSST-1 on IgE synthesis is not only due to the presence of
IL-4 and are consistent with the hypothesis of a bridge induced by
TSST-1 between Th 2 cells (primed in vivo) and B cells leading to
enhanced IgE production (Fig 5). Our observation suggests that,
when T cells are preactivated and shifted toward a Th2-like
cytokine profile, infectious agents can contribute to IgE-mediated
immune responses.
Next, we showed that the increased IgE production after
TSST-1 stimulation was associated with enhanced allergen-specific
IgE production. It is well established that symptoms following
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Table II. B7-2 expression on B cells is upregulated by TSST-1a
TSST-1 (pg per ml) %B7.11 B cells B7.21 B cells
Atopic Non-atopics All Atopic Non-atopics All
0 18.0 6 3.4 23.1 6 5.1 21.7 6 3.3 59.3 6 5.5 33.3 6 8.7 47.9 6 6.5
1 14.2 6 3.2* 21.4 6 5.1 17.8 6 3.1* 67.3 6 5.6* 47.9 6 3.6* 60.7 6 5.0*
105 14.9 6 4.5 22.2 6 5.7 17.0 6 3.1** 79.4 6 2.3** 53.5 6 10.0* 70.9 6 4.3**
aPBMC from five atopic patients and four non-atopic controls were stimulated for 48 h with TSST-1. After the culture, cells were harvested, stained with anti-CD19
fluorescein isothiocyanate-conjugated and anti-B7.1 or -B7.2 phycoerythrin-conjugated antibodies, and analyzed by flow cytometry. Results are expressed as mean 6SEM of
the nine experiments (medium versus TSST-1: *p , 0.05, **p , 0.005).
Figure 5. Proposed model of the effects of TSST-1 on allergen-
specific IgE responses. After stimulation with TSST-1 outside the pollen
season (A), bridging of Th 1 cells with B cells, in the presence of large
amounts of IFN-γ will inhibit allergen-specific IgE production. In contrast,
after stimulation with TSST-1 during the pollen season (B), very low
amounts of IFN-γ are secreted, and bridging TCR on Th 2 cells with
major histocompatibility complex class II by TSST-1 induces B cell
activation and subsequent allergen-specific IgE production.
allergen exposure are caused by allergen-specific IgE bound to
high-affinity receptors for IgE (FcεRI) on mast cells (Ishisaka,
1976), and which on cross-linking with allergens triggers release
of histamine and other inflammatory mediators (Segal et al, 1977).
This reaction requires very small amounts of allergen-specific IgE
produced by a small number of IgE-secreting B cells (MacKenzie
and Dosch, 1989). Moreover, IgE-switched specific B cell clones
remain activated long after allergen exposure and are committed
to the continuous production of allergen-specific IgE. This study
suggests that TSST-1 stimulates allergen-specific IgE-secreting B
cells, which can prolong and amplify IgE responses. We have
previously shown that TSST-1 cross-links T and B cells to induce
polyclonal B cell activation. For this reason, we believe that TSST-
1 is not acting like a simple antigen, but stimulates T and B cells
specific for other antigens, like pollen- or cat-allergens. This
suggests that TSST-1 has an adjuvant effect on IgE synthesis.
Bacterial superantigens are known to bridge the T cell receptor
on the T lymphocyte with class II major histocompatibility molecule
on the antigen-presenting cell (Mourad et al, 1989). As we have
shown previously, total IgE production is enhanced by TSST-1
after the superantigen has bridged T and B cells (Hofer et al, 1995).
In order to be activated after antigen presentation, T cells need, in
addition to the signal given through the T cell receptor, a
costimulatory signal. The B7 family of molecules expressed on
antigen-presenting cells such as B cells, deliver this costimulatory
signal after ligation of the CD28 T cell surface molecule. Based on
work done in mice, two members of the B7 family, B7.1 and
B7.2, appear to influence the type of Th cell activation differently
(Kuchroo et al, 1995). Glimcher et al regulated that antibodies to
B7.2 could nullify Th 2 differentiation in a Th 2-dominated mouse
(Kuchroo et al, 1995).
Recently, we demonstrated that B cells from asthmatic patients,
exposed to allergen, showed increased B7.2 expression, and that
B7.2 was upregulated on B cells by IL-4 (Hofer et al, 1998). The
functional significance of B7.2 induction by IL-4 in allergic diseases
is supported by recent studies demonstrating its direct involvement
in the induction of IgE synthesis (Jeannin et al, 1997), and by
recent data showing that B7.21 B cells produce more IgE than
B7.2– B cells. Furthermore, the role of B7.2 in IgE synthesis was
confirmed by the decrease of IgE production in cultures incubated
with anti-B7.2 antibodies (Jirapongsananuruk et al, 1998). Based
on the previous studies cited above, we conclude that TSST-1
enhances the IgE production by a mechanism involving B7.2
upregulation on B cells. In this study, we showed that B7.2, but
not B7.1, is upregulated on B cells after TSST-1 stimulation. This
increased B7.2 expression on B cells is likely to favor allergen
presentation and as a consequence stimulate the synthesis of allergen-
specific IgE.
In a previous study, we have shown that more than half of AD
patients are colonized with S. aureus secreting toxins, such TSST-
1 or staphylococcal enterotoxins. Furthermore, the serum of these
patients contained specific IgE against these toxins (Leung, 1995).
This study extends these observations to include a role for bacterial
toxins in the amplification of allergen-specific IgE production by
the following postulated pathway: during exposure to allergens,
IFN-γ production is decreased leading to a predominance of Th
2-like cytokines; TSST-1 bridges Th 2 cells and B cells inducing
B cell activation; TSST-1 upregulates B7.2 expression on B cells
and enhances IgE synthesis; IgE binds to CD23 allowing nonspecific
B cells to be potent antigen-presenting cells via the costimulatory
molecule B7.2. As a result, Th 2-like cells may expand and induce
more B cells to switch to IgE, with a subsequent overproduction
of IL-4 and allergen-specific IgE. This hypothesis may explain
how, in certain allergic patients, sensitivity only to one allergen
evolves to multiallergenicity. Thus in AD, TSST-1 may contribute
to sensitization to inhalant allergens, which promotes the subsequent
development of respiratory symptoms, as it is frequently seen in
the evolution of these patients. Our observation indicates a role
for S. aureus colonization in allergic sensitization of AD patients.
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In summary, this study demonstrates that TSST-1 is able to
augment IgE response against allergens. This adjuvant effect of
TSST-1 on IgE production is greatest when patients are undergoing
in vivo exposure to allergens, suggesting that exposure to superanti-
gens during the allergen season cross-links IL-4-producing Th 2
cells to B cells, which lead to enhanced IgE synthesis. These data
will provide new insights into potential mechanisms by which
infectious agents alter the course of allergic diseases.
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